CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life The year in cardiovascular medicine 2020: heart failure and cardiomyopathies Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure Heart Failure Outcomes With Volume-Guided Management Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis

Clinical TrialDecember 8, 2020 Vol 142, Issue 23

JOURNAL:Circulation. Article Link

Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial

F Cosentino , CP Cannon , DZI Cherney et al. Keywords: ertugliflozin;T2DM; ASCVD, HF

Full Text PDF